| Hans-Günter Meyer-Thompson | Benzodiazepine
The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
Alexandra M. Franklyn, Joseph K. Eibl, Graham Gauthier, David Pellegrini, Nancy K. Lightfoot and David C. Marsh
Harm Reduction Journal201714:6
DOI: 10.1186/s12954-017-0134-5
http://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0134-5